AI-Generated Drug Enters Mid-Stage Clinical Trials: A Breakthrough for Generative AI in Drug Discovery
Analysis
Key Takeaways
- •Rentosertib is an AI-generated drug targeting idiopathic pulmonary fibrosis.
- •It is the first AI-generated drug to reach mid-stage clinical trials.
- •The drug targets a novel biological pathway discovered by AI.
“…the first drug generated entirely by generative artificial intelligence to reach mid-stage human clinical trials, and the first to target a novel AI-discovered biological pathway”